Literature DB >> 9083932

Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma.

S André1, O Schatz, J R Bogner, H Zeichhardt, M Stöffler-Meilicke, H U Jahn, R Ullrich, A K Sonntag, R Kehm, J Haas.   

Abstract

Sequences of a new herpesvirus with homology to gammaherpesvirinae were recently identified in AIDS-associated Kaposi's sarcoma (KS). Subsequently this novel virus, called KS-associated virus (KSHV) or human herpesvirus (HHV) 8 was detected in classical KS and AIDS-associated body cavity based lymphomas by polymerase chain reaction. In this report major and minor capsid proteins of HHV-8 were molecularly cloned and produced as recombinant proteins in Escherichia coli. Sera from 69 HIV-1 infected patients with KS, 30 HIV-1 infected patients without KS and 106 control individuals were tested by enzyme-linked immunosorbent assay for anti-HHV-8 capsid IgM and IgG antibodies. Sera from four patients were tested over periods ranging from 18 months to 6 years. IgG antibodies directed against HHV-8 capsid antigens were detected in patients with AIDS-associated KS and in some AIDS patients without KS. Seroconversion with IgM and IgG antibodies directed against HHV-8 capsid proteins occurred more than 1 year prior to diagnosis of KS. In a considerable portion of KS patients no IgM or IgG antibodies against HHV-8 capsid proteins were detected. In these patients there was an inverse relationship between antibodies against HHV-8orf26 and the CD4/CD8 ratio, suggesting that the inconsistency of anti-HHV-8orf26 antibodies is due at least partly to an impaired immune response. No reactivity against HHV-8 capsid antigens was detected in the vast majority of sera from HIV-negative control individuals. Our findings indicate that a specific humoral immune response against capsid proteins is raised in HHV-8 infected individuals, and that anti-capsid antibodies can be used to diagnose HHV-8 infection. The correlation between occurrence of anti-HHV-8 antibodies and KS supports the hypothesis of a causative role of HHV-8.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083932     DOI: 10.1007/s001090050099

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  12 in total

1.  Capsid structure of Kaposi's sarcoma-associated herpesvirus, a gammaherpesvirus, compared to those of an alphaherpesvirus, herpes simplex virus type 1, and a betaherpesvirus, cytomegalovirus.

Authors:  B L Trus; J B Heymann; K Nealon; N Cheng; W W Newcomb; J C Brown; D H Kedes; A C Steven
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection.

Authors:  T J Spira; L Lam; S C Dollard; Y X Meng; C P Pau; J B Black; D Burns; B Cooper; M Hamid; J Huong; K Kite-Powell; P E Pellett
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  New immunofluorescence assays for detection of Human herpesvirus 8-specific antibodies.

Authors:  N Inoue; E C Mar; S C Dollard; C P Pau; Q Zheng; P E Pellett
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

4.  Persistent infection of Epstein-Barr virus-positive B lymphocytes by human herpesvirus 8.

Authors:  S Kliche; E Kremmer; W Hammerschmidt; U Koszinowski; J Haas
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma.

Authors:  H Katano; T Iwasaki; N Baba; M Terai; S Mori; A Iwamoto; T Kurata; T Sata
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  High human herpesvirus 8 seroprevalence in the homosexual population in Switzerland.

Authors:  N Regamey; G Cathomas; M Schwager; M Wernli; T Harr; P Erb
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

8.  Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.

Authors:  R Sun; S F Lin; K Staskus; L Gradoville; E Grogan; A Haase; G Miller
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus.

Authors:  Costin Tomescu; Wai K Law; Dean H Kedes
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1.

Authors:  M S Raab; J C Albrecht; A Birkmann; S Yağuboğlu; D Lang; B Fleckenstein; F Neipel
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.